Vascular miR-181b controls tissue factor-dependent thrombogenicity and inflammation in type 2 diabetes
Marco Witkowski(Cleveland Clinic), Ursula Rauch(Charité - Universitätsmedizin Berlin), Wolfram Ruf(Scripps Research Institute), Diethelm Tschoepe(Heart and Diabetes Center North Rhine-Westphalia), Samantha J. Winter(Goethe University Frankfurt), Bernd Stratmann(Heart and Diabetes Center North Rhine-Westphalia), Mona Saffarzadeh(Johannes Gutenberg University Mainz), Andreas Krueger(Justus-Liebig-Universität Gießen), Julian Friebel(Feuerwehr Dortmund), Mario Witkowski(Leibniz Association), Aritra Chakraborty(Kazi Nazrul University), Ulf Landmesser(Deutsches Herzzentrum der Charité), Termeh Tabaraie(Johannes Gutenberg University Mainz), Loc Ta Bao(Charité - Universitätsmedizin Berlin), Andrea Dörner(Charité - Universitätsmedizin Berlin)
Cited by 52
Related Papers
Low-density lipoproteins cause atherosclerotic cardiovascular disease. 1. Evidence from genetic, epidemiologic, and clinical studies. A consensus statement from the European Atherosclerosis Society Consensus Panel
|European Heart Journal|2017|3.8k
2016 ESC/EAS Guidelines for the Management of Dyslipidaemias
|European Heart Journal|2016|3.2k
2023 ESC Guidelines for the management of cardiomyopathies
|European Heart Journal|2023|2.3k
2023 ESC Guidelines for the management of endocarditis
|European Heart Journal|2023|1.6k